GHRH Analog
A synthetic 29-amino-acid peptide corresponding to the biologically active fragment (1–29) of human growth hormone-releasing hormone (GHRH). Studied as a tool for investigating pituitary-driven, pulsatile growth hormone release in research models.
In published research, Sermorelin is reconstituted with bacteriostatic water and administered subcutaneously, with literature protocols emphasizing low-volume, evening-timed dosing to align with natural GH pulses.
The endocrine-research community has long studied Sermorelin because it preserves the pulsatile architecture of native GH release rather than producing a sustained elevation. This makes it a useful comparator to direct GH administration in models of somatopause, body-composition changes, and GH-axis feedback dynamics.
For research purposes only. Not intended for consumption, clinical application, or diagnostic use.